$1,000-a-pill Sovaldi jolts U.S. health-care system

June 20, 2014 6:19 AM

13 0

$1,000-a-pill Sovaldi jolts U.S. health-care system

Sovaldi, a new pill for hepatitis C, cures the liver-wasting disease in 9 out of 10 patients, but treatment can cost more than $90,000.

Leading medical societies recommend the drug as a first-line treatment, and patients are clamoring for it. But insurance companies and state Medicaid programs are gagging on the price. In Oregon, officials propose to limit how many low-income patients can get Sovaldi.

Read more

To category page